Mimedx Group, Inc. (MDXG) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Mimedx reported revenue of $418.6M, up 20.0% from $348.9M the year before. Net income was $48.6M (a 11.6% net margin), or $0.32 per diluted share. Gross margin was 82.6% and operating margin was 15.3%. Operating activities generated $74.0M of cash. At fiscal year end, Mimedx held $342.7M in total assets against $86.1M in total liabilities, including $166.1M of cash and equivalents.
Open the full interactive Mimedx financials → Quarterly statements, key ratios, valuation history and price charts.
Mimedx Key Stats
| Share Price | $4.69 |
|---|---|
| Market Cap | $693.2M |
| P/E Ratio | 14.7 |
| Revenue YoY Growth | +20.0% |
| 52-Week Range | $3.09 – $7.96 |
| Shares Outstanding | 147.8 million (basic, 2026 Q2) |
Mimedx Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $248.2M | $258.6M | $267.8M | $321.5M | $348.9M | $418.6M |
| Cost of Goods Sold | $39.3M | $43.3M | $48.3M | $54.6M | $60.1M | $73.0M |
| Gross Profit | $208.9M | $215.3M | $219.5M | $266.8M | $288.8M | $345.6M |
| Operating Income | -$45.4M | -$5.0M | -$25.0M | $37.1M | $58.9M | $63.9M |
| Pre-Tax Income | -$61.5M | -$10.0M | -$30.0M | $30.6M | $57.3M | $66.3M |
| Income Tax | -$12.3M | $247,000 | $206,000 | -$36.8M | $15.3M | $17.7M |
| Net Income | -$49.3M | -$10.3M | -$30.2M | $58.2M | $42.4M | $48.6M |
| Diluted EPS | -$0.77 | -$0.15 | -$0.33 | $0.37 | $0.28 | $0.32 |
Mimedx Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $113.7M | $118.1M | $59.0M | $64.4M |
| Net Income | $16.7M | $15.2M | -$10.9M | -$14.8M |
| Diluted EPS | $0.11 | $0.10 | -$0.07 | -$0.10 |
Mimedx Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $95.8M | $87.1M | $66.0M | $82.0M | $104.4M | $166.1M |
| Current Assets | $160.6M | $148.5M | $134.2M | $164.3M | $191.9M | $277.5M |
| Total Assets | $202.0M | $187.9M | $171.4M | $239.0M | $263.9M | $342.7M |
| Current Liabilities | $59.2M | $42.4M | $43.6M | $46.0M | $45.6M | $64.3M |
| Total Long-Term Debt | $50.0M | $50.0M | $50.0M | $50.0M | $18.8M | $18.0M |
| Total Liabilities | $110.6M | $95.4M | $96.9M | $96.3M | $70.8M | $86.1M |
| Shareholders' Equity | -$150,000 | $82,000 | -$18.0M | $142.7M | $193.1M | $256.5M |
Mimedx Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$30.3M | -$2.0M | -$17.9M | $26.8M | $66.2M | $74.0M |
| Cash From Investing | -$4.6M | -$3.4M | -$2.7M | -$2.2M | -$9.6M | -$6.9M |
| Cash From Financing | $61.6M | -$3.4M | -$580,000 | -$8.6M | -$34.2M | -$5.4M |
| Free Cash Flow | — | — | — | $24.8M | — | — |
Figures from Mimedx's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Mimedx financials page for every line item.
Mimedx Company Profile
| Ticker | MDXG |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Marietta, Georgia |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001376339 |
Frequently Asked Questions
What was Mimedx's revenue in fiscal 2025?
Mimedx (MDXG) reported revenue of $418.6M for fiscal 2025.
What is Mimedx's annual revenue history?
Mimedx's annual revenue by fiscal year: 2020: $248.2M; 2021: $258.6M; 2022: $267.8M; 2023: $321.5M; 2024: $348.9M; 2025: $418.6M.
What was Mimedx's net income in fiscal 2025?
Mimedx reported net income of $48.6M for fiscal 2025.
What was Mimedx's earnings per share (EPS) in fiscal 2025?
Mimedx's diluted EPS was $0.32 for fiscal 2025 (adjusted for any later stock splits).
What was Mimedx's revenue last quarter?
In its most recent reported quarter (2026 Q2), Mimedx reported revenue of $64.4M.
How much debt does Mimedx have?
Mimedx reported $18.0M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Mimedx are outstanding?
Mimedx reported a weighted average of 147.8 million basic shares outstanding in 2026 Q2.
What is Mimedx's market cap?
Based on its latest closing price, Mimedx (MDXG) has a market capitalization of about $693.2M.
When does Mimedx's fiscal year end?
Mimedx's fiscal year end, as registered with the SEC, is December 31.
Where is Mimedx headquartered?
Mimedx lists its business address in Marietta, Georgia in its SEC filings.
Mimedx Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →